local
Vaccine to treat ‘neglected disease’ shows promising results
Summary by The Midland Editorial Desk Katelyn Carlock , as published by KOSA CBS7 / First Alert 7 (Permian Basin CBS)
· July 1, 2026
· 1 min read
Photo: KOSA CBS7 / First Alert 7 (Permian Basin CBS) · view original
Story provenance No corrections
Summary created by The Midland Editorial Desk — automated, rule-governed Byline on source page Katelyn Carlock, as published by KOSA CBS7 / First Alert 7 (Permian Basin CBS) Original story Read at the source Source published Jul 1, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key points Further details on the vaccine and its development are available from Texas Tech University Health Sciences Center, as reported by KOSA CBS7. Researchers at Texas Tech University Health Sciences Center have made progress on a vaccine for a parasitic illness.
Researchers at Texas Tech University Health Sciences Center have made progress on a vaccine for a parasitic illness. The vaccine, called SchistoShield, is intended to treat schistosomiasis, a disease that affects millions of people worldwide.
The researchers have reported encouraging early results from their work on the vaccine, which has been in development for years.
Further details on the vaccine and its development are available from Texas Tech University Health Sciences Center, as reported by KOSA CBS7.
More local Today’s briefing Local events
Why this matters
Local news anchors readers in their community — the people, places, and decisions that shape day-to-day life. The Midland covers these stories because national outlets often won't.
About this story
As published by KOSA CBS7 / First Alert 7 (Permian Basin CBS) . The Midland surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KOSA CBS7 / First Alert 7 (Permian Basin CBS) . Have a tip or correction? Contact our newsroom .
Category: local Published: July 1, 2026 Source: KOSA CBS7 / First Alert 7 (Permian Basin CBS) Reading time: 1 min
Frequently asked about this story
What is this story about? Researchers at Texas Tech University Health Sciences Center have made progress on a vaccine for a parasitic illness. The vaccine, called SchistoShield, is intended to treat schistosomiasis, a disease…
When was this published? This article was first published on July 1, 2026 by KOSA CBS7 / First Alert 7 (Permian Basin CBS) and curated for The Midland readers.
Who reported this story? This story was reported by Katelyn Carlock at KOSA CBS7 / First Alert 7 (Permian Basin CBS). To learn more about how The Midland selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The Midland, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter
